vs
Side-by-side financial comparison of GERON CORP (GERN) and INDEPENDENT BANK CORP (IBCP). Click either name above to swap in a different company.
INDEPENDENT BANK CORP is the larger business by last-quarter revenue ($58.9M vs $47.2M, roughly 1.2× GERON CORP). INDEPENDENT BANK CORP runs the higher net margin — 28.6% vs -39.0%, a 67.7% gap on every dollar of revenue. Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 2.1%).
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
Independent Bank is a bank headquartered in Grand Rapids, Michigan. The bank has 62 branches, all of which are in Michigan.
GERN vs IBCP — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $58.9M |
| Net Profit | $-18.4M | $16.9M |
| Gross Margin | — | — |
| Operating Margin | -29.4% | — |
| Net Margin | -39.0% | 28.6% |
| Revenue YoY | 67.1% | — |
| Net Profit YoY | 30.3% | 8.2% |
| EPS (diluted) | $-0.03 | $0.81 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $58.9M | ||
| Q4 25 | — | $58.3M | ||
| Q3 25 | $47.2M | $57.3M | ||
| Q2 25 | $49.0M | $55.9M | ||
| Q1 25 | $39.6M | $54.1M | ||
| Q4 24 | — | $62.0M | ||
| Q3 24 | $28.3M | $51.4M | ||
| Q2 24 | $882.0K | $56.5M |
| Q1 26 | — | $16.9M | ||
| Q4 25 | — | $18.6M | ||
| Q3 25 | $-18.4M | $17.5M | ||
| Q2 25 | $-16.4M | $16.9M | ||
| Q1 25 | $-19.8M | $15.6M | ||
| Q4 24 | — | $18.5M | ||
| Q3 24 | $-26.4M | $13.8M | ||
| Q2 24 | $-67.4M | $18.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 34.8% | ||
| Q3 25 | -29.4% | 37.0% | ||
| Q2 25 | -25.4% | 37.0% | ||
| Q1 25 | -42.2% | 35.3% | ||
| Q4 24 | — | 36.7% | ||
| Q3 24 | -99.8% | 33.7% | ||
| Q2 24 | -7860.9% | 41.0% |
| Q1 26 | — | 28.6% | ||
| Q4 25 | — | 31.8% | ||
| Q3 25 | -39.0% | 30.5% | ||
| Q2 25 | -33.4% | 30.2% | ||
| Q1 25 | -50.1% | 28.8% | ||
| Q4 24 | — | 29.8% | ||
| Q3 24 | -93.5% | 26.9% | ||
| Q2 24 | -7639.8% | 32.8% |
| Q1 26 | — | $0.81 | ||
| Q4 25 | — | $0.88 | ||
| Q3 25 | $-0.03 | $0.84 | ||
| Q2 25 | $-0.02 | $0.81 | ||
| Q1 25 | $-0.03 | $0.74 | ||
| Q4 24 | — | $0.87 | ||
| Q3 24 | $-0.04 | $0.65 | ||
| Q2 24 | $-0.10 | $0.88 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.1M | $174.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $248.7M | $510.6M |
| Total Assets | $567.4M | $5.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $174.9M | ||
| Q4 25 | — | $138.4M | ||
| Q3 25 | $78.1M | $208.7M | ||
| Q2 25 | $77.7M | $146.2M | ||
| Q1 25 | $83.7M | $128.1M | ||
| Q4 24 | — | $119.9M | ||
| Q3 24 | $60.3M | $121.6M | ||
| Q2 24 | $116.9M | $214.3M |
| Q1 26 | — | $510.6M | ||
| Q4 25 | — | $503.0M | ||
| Q3 25 | $248.7M | $490.7M | ||
| Q2 25 | $259.5M | $469.3M | ||
| Q1 25 | $268.2M | $467.3M | ||
| Q4 24 | — | $454.7M | ||
| Q3 24 | $292.3M | $452.4M | ||
| Q2 24 | $306.7M | $430.5M |
| Q1 26 | — | $5.6B | ||
| Q4 25 | — | $5.5B | ||
| Q3 25 | $567.4M | $5.5B | ||
| Q2 25 | $555.2M | $5.4B | ||
| Q1 25 | $562.5M | $5.3B | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | $444.9M | $5.3B | ||
| Q2 24 | $449.4M | $5.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.6M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $76.7M | ||
| Q3 25 | $-13.6M | $18.2M | ||
| Q2 25 | $-27.4M | $19.0M | ||
| Q1 25 | $-48.0M | $31.7M | ||
| Q4 24 | — | $63.2M | ||
| Q3 24 | $-58.9M | $17.2M | ||
| Q2 24 | $-53.5M | $8.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $70.2M | ||
| Q3 25 | — | $16.5M | ||
| Q2 25 | — | $16.7M | ||
| Q1 25 | — | $30.6M | ||
| Q4 24 | — | $55.2M | ||
| Q3 24 | — | $15.7M | ||
| Q2 24 | $-53.7M | $7.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 120.3% | ||
| Q3 25 | — | 28.9% | ||
| Q2 25 | — | 29.8% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | 89.1% | ||
| Q3 24 | — | 30.6% | ||
| Q2 24 | -6086.6% | 12.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 11.1% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 4.1% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 12.8% | ||
| Q3 24 | 0.0% | 2.9% | ||
| Q2 24 | 23.4% | 3.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.13× | ||
| Q3 25 | — | 1.04× | ||
| Q2 25 | — | 1.12× | ||
| Q1 25 | — | 2.03× | ||
| Q4 24 | — | 3.42× | ||
| Q3 24 | — | 1.25× | ||
| Q2 24 | — | 0.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GERN
Segment breakdown not available.
IBCP
| Net Interest Income | $46.9M | 80% |
| Noninterest Income | $12.0M | 20% |
